Report Detail
Global Antidiabetic Drug Market Research Report 2019
- RnM3122765 |
- 14 March, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Pharma & Healthcare
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.
The global Antidiabetic Drug market is valued at 49600 million US$ in 2018 is expected to reach 96700 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2019-2025.
This report focuses on Antidiabetic Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antidiabetic Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
Segment by Application
Type I Diabetes
Type II Diabetes
Table of Contents
Executive Summary
1 Antidiabetic Drug Market Overview
- 1.1 Product Overview and Scope of Antidiabetic Drug
- 1.2 Antidiabetic Drug Segment by Type
- 1.2.1 Global Antidiabetic Drug Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Alpha-Glucosidase Inhibitors
- 1.2.3 Biguanides, Sulphonylureas
- 1.2.4 Glp-1 Agonist
- 1.2.5 Meglitinides
- 1.2.6 Dpp-4 Inhibitors
- 1.2.7 Sglt–2
- 1.2.8 Thiazolodinediones
- 1.3 Antidiabetic Drug Segment by Application
- 1.3.1 Antidiabetic Drug Consumption Comparison by Application (2014-2025)
- 1.3.2 Type I Diabetes
- 1.3.3 Type II Diabetes
- 1.4 Global Antidiabetic Drug Market by Region
- 1.4.1 Global Antidiabetic Drug Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Antidiabetic Drug Market Size
- 1.5.1 Global Antidiabetic Drug Revenue (2014-2025)
- 1.5.2 Global Antidiabetic Drug Production (2014-2025)
2 Global Antidiabetic Drug Market Competition by Manufacturers
- 2.1 Global Antidiabetic Drug Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Antidiabetic Drug Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Antidiabetic Drug Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Antidiabetic Drug Production Sites, Area Served, Product Types
- 2.5 Antidiabetic Drug Market Competitive Situation and Trends
- 2.5.1 Antidiabetic Drug Market Concentration Rate
- 2.5.2 Antidiabetic Drug Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Antidiabetic Drug Production Market Share by Regions
- 3.1 Global Antidiabetic Drug Production Market Share by Regions
- 3.2 Global Antidiabetic Drug Revenue Market Share by Regions (2014-2019)
- 3.3 Global Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Antidiabetic Drug Production
- 3.4.1 North America Antidiabetic Drug Production Growth Rate (2014-2019)
- 3.4.2 North America Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Antidiabetic Drug Production
- 3.5.1 Europe Antidiabetic Drug Production Growth Rate (2014-2019)
- 3.5.2 Europe Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Antidiabetic Drug Production (2014-2019)
- 3.6.1 China Antidiabetic Drug Production Growth Rate (2014-2019)
- 3.6.2 China Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Antidiabetic Drug Production (2014-2019)
- 3.7.1 Japan Antidiabetic Drug Production Growth Rate (2014-2019)
- 3.7.2 Japan Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Antidiabetic Drug Consumption by Regions
- 4.1 Global Antidiabetic Drug Consumption by Regions
- 4.2 North America Antidiabetic Drug Consumption (2014-2019)
- 4.3 Europe Antidiabetic Drug Consumption (2014-2019)
- 4.4 China Antidiabetic Drug Consumption (2014-2019)
- 4.5 Japan Antidiabetic Drug Consumption (2014-2019)
5 Global Antidiabetic Drug Production, Revenue, Price Trend by Type
- 5.1 Global Antidiabetic Drug Production Market Share by Type (2014-2019)
- 5.2 Global Antidiabetic Drug Revenue Market Share by Type (2014-2019)
- 5.3 Global Antidiabetic Drug Price by Type (2014-2019)
- 5.4 Global Antidiabetic Drug Production Growth by Type (2014-2019)
6 Global Antidiabetic Drug Market Analysis by Applications
- 6.1 Global Antidiabetic Drug Consumption Market Share by Application (2014-2019)
- 6.2 Global Antidiabetic Drug Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Antidiabetic Drug Business
- 7.1 Sanofi-Aventis
- 7.1.1 Sanofi-Aventis Antidiabetic Drug Production Sites and Area Served
- 7.1.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.1.3 Sanofi-Aventis Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Eli Lilly
- 7.2.1 Eli Lilly Antidiabetic Drug Production Sites and Area Served
- 7.2.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.2.3 Eli Lilly Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Oramed
- 7.3.1 Oramed Antidiabetic Drug Production Sites and Area Served
- 7.3.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.3.3 Oramed Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Takeda
- 7.4.1 Takeda Antidiabetic Drug Production Sites and Area Served
- 7.4.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.4.3 Takeda Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Boehringer Ingelheim
- 7.5.1 Boehringer Ingelheim Antidiabetic Drug Production Sites and Area Served
- 7.5.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.5.3 Boehringer Ingelheim Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Novo Nordisk
- 7.6.1 Novo Nordisk Antidiabetic Drug Production Sites and Area Served
- 7.6.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.6.3 Novo Nordisk Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Halozyme Therapeutics
- 7.7.1 Halozyme Therapeutics Antidiabetic Drug Production Sites and Area Served
- 7.7.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.7.3 Halozyme Therapeutics Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Bristol-Myers Squibb
- 7.8.1 Bristol-Myers Squibb Antidiabetic Drug Production Sites and Area Served
- 7.8.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.8.3 Bristol-Myers Squibb Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Pfizer
- 7.9.1 Pfizer Antidiabetic Drug Production Sites and Area Served
- 7.9.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.9.3 Pfizer Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Tonghua Dongbao
- 7.10.1 Tonghua Dongbao Antidiabetic Drug Production Sites and Area Served
- 7.10.2 Antidiabetic Drug Product Introduction, Application and Specification
- 7.10.3 Tonghua Dongbao Antidiabetic Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 Biocon
- 7.12 Wockhardt
8 Antidiabetic Drug Manufacturing Cost Analysis
- 8.1 Antidiabetic Drug Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Antidiabetic Drug
- 8.4 Antidiabetic Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Antidiabetic Drug Distributors List
- 9.3 Antidiabetic Drug Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Antidiabetic Drug Market Forecast
- 11.1 Global Antidiabetic Drug Production, Revenue Forecast
- 11.1.1 Global Antidiabetic Drug Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Antidiabetic Drug Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Antidiabetic Drug Price and Trend Forecast (2019-2025)
- 11.2 Global Antidiabetic Drug Production Forecast by Regions (2019-2025)
- 11.2.1 North America Antidiabetic Drug Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Antidiabetic Drug Production, Revenue Forecast (2019-2025)
- 11.2.3 China Antidiabetic Drug Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Antidiabetic Drug Production, Revenue Forecast (2019-2025)
- 11.3 Global Antidiabetic Drug Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Antidiabetic Drug Consumption Forecast (2019-2025)
- 11.3.2 Europe Antidiabetic Drug Consumption Forecast (2019-2025)
- 11.3.3 China Antidiabetic Drug Consumption Forecast (2019-2025)
- 11.3.4 Japan Antidiabetic Drug Consumption Forecast (2019-2025)
- 11.4 Global Antidiabetic Drug Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Antidiabetic Drug Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Antidiabetic Drug . Industry analysis & Market Report on Antidiabetic Drug is a syndicated market report, published as Global Antidiabetic Drug Market Research Report 2019. It is complete Research Study and Industry Analysis of Antidiabetic Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
